Table 4.
Categories | Antibody Formats | Specific Site Used | Conjugation Chemistry | MOA of siRNA | References |
---|---|---|---|---|---|
Non-covalent complex with peptide or polymer | Fab, scFv | Protamine fused | Noncovalent complex | In vitro and in vivo gene knockdown | [106] |
scFv | Conjugated with Cys oligo-9 arginine | Noncovalent complex | Antiviral in vivo | [107] | |
scFv | Protamine fused | Noncovalent complex | In vitro gene knockdown | [108] | |
scFv | Protamine fused | Noncovalent complex | Antiviral in vivo | [109] | |
Ab, Fab | Conjugated unnatural amino acid with cationic copolymer | Noncovalent complex | In vitro gene knockdown | [110] | |
scFv | Protamine fused | Noncovalent complex | Anticancer | [111] | |
Direct conjugation | Ab | Cys | THIOMABTM | In vitro and in vivo gene knockdown | [112] |
Fab | Cys | Thiol-mediated conjugation | In vivo gene knockdown in muscle | [113] | |
Nb | Cys | Thiol-mediated conjugation | In vitro gene knockdown | [114] | |
Ab | Engineered Lys | Lys-β-lactam | In vitro gene knockdown | [115] |